Literature DB >> 10465065

Hydroxyurea and HIV: 5 years later--from antiviral to immune-modulating effects.

F Lori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465065     DOI: 10.1097/00002030-199908200-00001

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.

Authors:  Katyna Borroto-Esoda; Florence Myrick; Joy Feng; Jerry Jeffrey; Phillip Furman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 2.  Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Authors:  Julianna Lisziewicz; Andrea Foli; Mark Wainberg; Franco Lori
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation.

Authors:  J M Benito; M López; S Lozano; C Ballesteros; J González-Lahoz; V Soriano
Journal:  Clin Exp Immunol       Date:  2007-05-18       Impact factor: 4.330

4.  Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox.

Authors:  Mohammed S Inayat; Ismail S El-Amouri; Mohammad Bani-Ahmad; Howard L Elford; Vincent S Gallicchio; Oliver R Oakley
Journal:  J Inflamm (Lond)       Date:  2010-08-18       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.